(Q45139621)

9 December 2017

123I-IMT SPECT and 1H MR-spectroscopy at 3.0 T in the differential diagnosis of recurrent or residual gliomas: a comparative study (English)

1 reference

9 December 2017

3

1 reference

9 December 2017

Florian Stockhammer

6

0 references

author name string

Michail Plotkin

1

1 reference

9 December 2017

Julia Eisenacher

2

1 reference

9 December 2017

Reinhard Wurm

4

1 reference

9 December 2017

Roger Michel

5

1 reference

9 December 2017

Annelie Feussner

7

1 reference

9 December 2017

Oliver Dudeck

8

1 reference

9 December 2017

Peter Wust

9

1 reference

9 December 2017

Roland Felix

10

1 reference

9 December 2017

Holger Amthauer

11

1 reference

9 December 2017

1 October 2004

1 reference

Journal of Neuro-Oncology

9 December 2017

1 reference

9 December 2017

70

1 reference

9 December 2017

1

1 reference

9 December 2017

49-58

1 reference

https://scigraph.springernature.com/pub.10.1023/b:neon.0000040810.77270.68

9 December 2017

0 references

cites work

Proton MR spectroscopic evaluation of suspicious brain lesions after stereotactic radiotherapy.

1 reference

12 December 2020

Noninvasive differentiation of tumors with use of localized H-1 MR spectroscopy in vivo: initial experience in patients with cerebral tumors.

1 reference

12 December 2020

The new WHO classification of brain tumours

1 reference

12 December 2020

201Thallium SPECT and 1H-MRS compared with MRI in chemotherapy monitoring of high-grade malignant astrocytomas.

1 reference

12 December 2020

Imaging of brain tumors after therapy.

1 reference

12 December 2020

Clinical value of iodine-123-alpha-methyl-L-tyrosine single-photon emission tomography in the differential diagnosis of recurrent brain tumor in patients pretreated for glioma at follow-up

1 reference

12 December 2020

1 reference

12 December 2020

Iodine-123-alpha-methyl tyrosine in gliomas: correlation with cellular density and proliferative activity.

1 reference

12 December 2020

Quantitative proton magnetic resonance spectroscopy of focal brain lesions.

1 reference

12 December 2020

On the interpretation of proton NMR spectra from brain tumours in vivo and in vitro.

1 reference

12 December 2020

Localized proton NMR spectroscopy of brain tumors using short-echo time STEAM sequences.

1 reference

12 December 2020

[Uptake of DL-3-123I-iodo-alpha-methyltyrosine in recurrent brain tumors]

1 reference

12 December 2020

Glial neoplasms without elevated choline-creatine ratios

1 reference

12 December 2020

In vivo 3-T MR spectroscopy in the distinction of recurrent glioma versus radiation effects: initial experience

1 reference

12 December 2020

Comparison of iodotyrosines and methionine uptake in a rat glioma model

1 reference

12 December 2020

Clinical value of proton magnetic resonance spectroscopy for differentiating recurrent or residual brain tumor from delayed cerebral necrosis.

1 reference

12 December 2020

O-(2-[18F]fluoroethyl)-L-tyrosine and L-[methyl-11C]methionine uptake in brain tumours: initial results of a comparative study

1 reference

12 December 2020

Clinical positron emission tomography for brain tumors: comparison of fludeoxyglucose F 18 and L-methyl-11C-methionine.

1 reference

12 December 2020

Imaging of brain tumors with L-3-[123I]iodo-alpha-methyl tyrosine and SPECT.

1 reference

12 December 2020

Human brain tumors: spectral patterns detected with localized H-1 MR spectroscopy

1 reference

12 December 2020

Metabolism of human gliomas: assessment with H-1 MR spectroscopy and F-18 fluorodeoxyglucose PET.

1 reference

12 December 2020

Diagnosis of recurrent glioma with SPECT and iodine-123-alpha-methyl tyrosine.

1 reference

12 December 2020

Uptake of 11C-L- and D-methionine in brain tumors.

1 reference

12 December 2020

Multivoxel 3D proton spectroscopy in the brain at 1.5 versus 3.0 T: signal-to-noise ratio and resolution comparison.

1 reference

12 December 2020

3-[123I]iodo-alpha-methyltyrosine and [methyl-11C]-L-methionine uptake in cerebral gliomas: a comparative study using SPECT and PET.

1 reference

12 December 2020

Evaluation of brain tumor metabolism with [11C]choline PET and 1H-MRS.

1 reference

12 December 2020

Unusual MR spectroscopic imaging pattern of an astrocytoma: lack of elevated choline and high myo-inositol and glycine levels.

1 reference

12 December 2020

Mapping of brain tumor metabolites with proton MR spectroscopic imaging: clinical relevance

1 reference

12 December 2020

Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy.

1 reference

12 December 2020

Preoperative proton MR spectroscopic imaging of brain tumors: correlation with histopathologic analysis of resection specimens

1 reference

12 December 2020

Current imaging techniques for the evaluation of brain neoplasms.

1 reference

12 December 2020

1H-MR Spectroscopy of brain tumors in the course of radiation therapy: Use of fast spectroscopic imaging and single-voxel spectroscopy for diagnosing recurrence

1 reference

12 December 2020

Implications of IMT-SPECT for postoperative radiotherapy planning in patients with gliomas

1 reference

12 December 2020

3-[(123)I]Iodo-alpha-methyl-L-tyrosine: uptake mechanisms and clinical applications.

1 reference

12 December 2020

Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxyglucose and/or carbon-11-methionine.

1 reference

12 December 2020

Influence of size of regions of interest on the measurement of uptake of 123I-alpha-methyl tyrosine by brain tumours

1 reference

12 December 2020

Direct n.c.a. electrophilic radioiodination of tyrosine analogues; their in vivo stability and brain-uptake in mice

1 reference

12 December 2020

10.1023/B:NEON.0000040810.77270.68

Identifiers

DOI

1 reference

Dimensions Publication ID

9 December 2017

0 references

1 reference